BACKGROUND AND STUDY AIM: In a quality assessment project for endoscopic retrograde cholangiopancreatography (ERCP), initiated in 2006 by the Austrian Society of Gastroenterology and Hepatology, benchmark data were collected on a voluntary basis. Results from the individual participating centers, both academic and community-based, were compared with pooled benchmark data, with the intention that individual problems should be identified and corrected in order to improve patient care in Austria. Success and complication rates in nonselected patients were evaluated, especially with regard to case volume. METHODS: In Austria, with a population of 8 million, 140 sites are registered for ERCP, and it is estimated that up to 15 000 procedures are done annually. Of these sites, 28 participated in the "Benchmarking ERCP" project during the first year, reporting on 3132 procedures, or 22 % of the total number. RESULTS: The overall complication rate in nonselected patients was 12.6 %, consisting of post-ERCP pancreatitis (5.1 %), bleeding (3.7 %), cholangitis (1.9 %), cardiopulmonary complications (0.9 %), and perforation (0.5 %); procedure-related mortality was 0.1 %. The overall therapeutic and diagnostic target was achieved in 84.8 %. High case volume (endoscopists performing > 50 vs. < 50 ERCPs per year; 21 vs. 68 endoscopists) was associated with significantly higher success (86.9 % vs. 80.3 %, P < 0.001) and lower overall complication rates (10.2 % vs. 13.6 %, P = 0.007); significance was not reached for all subgroups of complications. CONCLUSION: Success and complication rates for ERCP in Austria are comparable to those reported elsewhere. In our study, endoscopists with a case volume exceeding 50 ERCPs per year had higher success and lower overall complication rates.
BACKGROUND AND STUDY AIM: In a quality assessment project for endoscopic retrograde cholangiopancreatography (ERCP), initiated in 2006 by the Austrian Society of Gastroenterology and Hepatology, benchmark data were collected on a voluntary basis. Results from the individual participating centers, both academic and community-based, were compared with pooled benchmark data, with the intention that individual problems should be identified and corrected in order to improve patient care in Austria. Success and complication rates in nonselected patients were evaluated, especially with regard to case volume. METHODS: In Austria, with a population of 8 million, 140 sites are registered for ERCP, and it is estimated that up to 15 000 procedures are done annually. Of these sites, 28 participated in the "Benchmarking ERCP" project during the first year, reporting on 3132 procedures, or 22 % of the total number. RESULTS: The overall complication rate in nonselected patients was 12.6 %, consisting of post-ERCP pancreatitis (5.1 %), bleeding (3.7 %), cholangitis (1.9 %), cardiopulmonary complications (0.9 %), and perforation (0.5 %); procedure-related mortality was 0.1 %. The overall therapeutic and diagnostic target was achieved in 84.8 %. High case volume (endoscopists performing > 50 vs. < 50 ERCPs per year; 21 vs. 68 endoscopists) was associated with significantly higher success (86.9 % vs. 80.3 %, P < 0.001) and lower overall complication rates (10.2 % vs. 13.6 %, P = 0.007); significance was not reached for all subgroups of complications. CONCLUSION: Success and complication rates for ERCP in Austria are comparable to those reported elsewhere. In our study, endoscopists with a case volume exceeding 50 ERCPs per year had higher success and lower overall complication rates.
Authors: Douglas G Adler; John G Lieb; Jonathan Cohen; Irving M Pike; Walter G Park; Maged K Rizk; Mandeep S Sawhney; James M Scheiman; Nicholas J Shaheen; Stuart Sherman; Sachin Wani Journal: Am J Gastroenterol Date: 2014-12-02 Impact factor: 10.864
Authors: David I Fudman; Charles J Lightdale; John M Poneros; Gregory G Ginsberg; Gary W Falk; Maureen Demarshall; Milli Gupta; Prasad G Iyer; Lori Lutzke; Kenneth K Wang; Julian A Abrams Journal: Gastrointest Endosc Date: 2014-02-22 Impact factor: 9.427
Authors: Evan L Fogel; Safi Shahda; Kumar Sandrasegaran; John DeWitt; Jeffrey J Easler; David M Agarwal; Mackenzie Eagleson; Nicholas J Zyromski; Michael G House; Susannah Ellsworth; Ihab El Hajj; Bert H O'Neil; Attila Nakeeb; Stuart Sherman Journal: Am J Gastroenterol Date: 2017-01-31 Impact factor: 10.864
Authors: Timothy D Imler; Stuart Sherman; Thomas F Imperiale; Huiping Xu; Fangqian Ouyang; Christopher Beesley; Charity Hilton; Gregory A Coté Journal: Gastrointest Endosc Date: 2017-05-03 Impact factor: 9.427
Authors: Anthony T DeBenedet; B Joseph Elmunzer; Sean T McCarthy; Grace H Elta; Philip S Schoenfeld Journal: Am J Gastroenterol Date: 2013-07-23 Impact factor: 10.864
Authors: Jaap J Kloek; Niels A van der Gaag; Yalda Aziz; Erik A J Rauws; Otto M van Delden; Johan S Lameris; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik Journal: J Gastrointest Surg Date: 2009-09-15 Impact factor: 3.452